Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.
Cancer Res Commun. 2022 May;2(5):342-352. doi: 10.1158/2767-9764.crc-21-0176. Epub 2022 May 10.
Cancer Res Commun. 2022.
PMID: 35573474
Free PMC article.
Connecting the Human Microbiome and Pancreatic Cancer.
Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, Nagasaka M, El-Rayes B, Azmi AS.
Sexton RE, et al. Among authors: mzannar y.
Cancer Metastasis Rev. 2022 Jun;41(2):317-331. doi: 10.1007/s10555-022-10022-w. Epub 2022 Apr 2.
Cancer Metastasis Rev. 2022.
PMID: 35366155
Free PMC article.
Review.
Item in Clipboard
Correction to: Connecting the human microbiome and pancreatic cancer.
Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, Nagasaka M, El-Rayes B, Azmi AS.
Sexton RE, et al. Among authors: mzannar y.
Cancer Metastasis Rev. 2022 Jun;41(2):333. doi: 10.1007/s10555-022-10037-3.
Cancer Metastasis Rev. 2022.
PMID: 35536453
Free PMC article.
No abstract available.
Item in Clipboard
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Uddin MH, Al-Hallak MN, Khan HY, Aboukameel A, Li Y, Bannoura SF, Dyson G, Kim S, Mzannar Y, Azar I, Odisho T, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Philip PA, Shields AF, Azmi AS.
Uddin MH, et al. Among authors: mzannar y.
Clin Transl Med. 2023 Dec;13(12):e1513. doi: 10.1002/ctm2.1513.
Clin Transl Med. 2023.
PMID: 38131168
Free PMC article.
Item in Clipboard
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.
Khan HY, Nagasaka M, Aboukameel A, Alkhalili O, Uddin MH, Bannoura SF, Mzannar Y, Azar I, Beal EW, Tobon ME, Kim SH, Beydoun R, Baloglu E, Senapedis W, El-Rayes BF, Philip PA, Mohammad RM, Shields AF, Al Hallak MN, Azmi AS.
Khan HY, et al. Among authors: mzannar y.
Mol Cancer Ther. 2023 Dec 1;22(12):1422-1433. doi: 10.1158/1535-7163.MCT-23-0251.
Mol Cancer Ther. 2023.
PMID: 37703579
Free PMC article.
Item in Clipboard
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers.
Khan HY, Nagasaka M, Aboukameel A, Alkhalili O, Uddin MH, Bannoura S, Mzannar Y, Azar I, Beal E, Tobon M, Kim S, Beydoun R, Baloglu E, Senapedis W, El-Rayes B, Philip PA, Mohammad RM, Shields AF, Al-Hallak MN, Azmi AS.
Khan HY, et al. Among authors: mzannar y.
bioRxiv [Preprint]. 2023 Mar 27:2023.03.27.534309. doi: 10.1101/2023.03.27.534309.
bioRxiv. 2023.
PMID: 37034616
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite